Federal Court of Australia approves Incannex’s re-domiciliation

Incannex Healthcare announced that the Federal Court of Australia has today made orders approving the scheme of arrangement in relation to the Company’s proposed re-domiciliation from Australia to the United States, under which Incannex Healthcare will become the ultimate parent company of Incannex Healthcare Limited following the implementation of the Scheme. It is expected that a copy of the Court’s orders with respect to the Schemes will be lodged with ASIC tomorrow, at which time the Schemes will become legally effective. Incannex has applied to ASX to suspend quotation and trading of Incannex shares, with effect from the close of trading on ASX on November 17, 2023. Incannex’s ADRs, however, will continue to trade on Nasdaq until the implementation date. Incannex shareholders and optionholders who hold shares and options on the record date for the Scheme. The Scheme consideration will be paid to Scheme Shareholders and Scheme Optionholders on the implementation date.